Precision medicine and precision diagnostics are increasingly recognized as two parts of a single, integrated system, yet many healthcare organizations still treat them as separate processes—limiting their potential impact. In this article, author Matt Phillion highlights insights from Avalon CEO Bill Kerr, MD, who argues the industry is at an inflection point where diagnostics are no longer just inputs, but active drivers of care quality, timing, and value. When aligned, precision diagnostics enable earlier, more accurate diagnoses and more targeted treatment decisions, improving outcomes while reducing unnecessary testing and delays.
However, realizing this full potential requires overcoming structural and operational barriers, including slow adoption of new therapies, fragmented workflows, and gaps in provider education. Advances in data integration and AI are beginning to close these gaps by helping clinicians connect diagnostic insights with treatment pathways more efficiently. As targeted therapies continue to evolve, the convergence of precision diagnostics and precision medicine will be essential to delivering faster, more personalized, and more effective care across a wide range of conditions.
Read the full article in Patient Safety and Quality Healthcare to explore how integrating precision diagnostics and precision medicine can improve patient outcomes.
